Efficacy and safety of simtuzumab for the treatment of nonalcoholic steatohepatitis with bridging fibrosis or cirrhosis: results of two phase 2b, dose-ranging, randomized, placebo-controlled trials

Authors:
  • ASA. Sanyal
    A. Sanyal
  • MAM.F. Abdelmalek
    M.F. Abdelmalek
  • ADA.M. Diehl
    A.M. Diehl
  • SCS. Caldwell
    S. Caldwell
  • MSM.L. Shiffman
    M.L. Shiffman
  • RGR. Ghalib
    R. Ghalib
  • ELE. Lawitz
    E. Lawitz
  • DRD.C. Rockey
    D.C. Rockey
  • RSR.A. Schall
    R.A. Schall
  • CJC. Jia
    C. Jia
  • BMB.J. McColgan
    B.J. McColgan
  • RMR. Myers
    R. Myers
Publisher website
Google Scholar
Abstract
No abstract available